Abstract
4005 Background: RAINBOW, a global phase III trial, demonstrated significant improvements in overall survival (OS), progression-free survival (PFS), and objective response rate (ORR) in patients (p...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have